drugset / Trial / NCT04100083

Spironolactone for Hidradenitis Suppurativa

NCT04100083

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate if the drug spironolactone - which is used to treat acne and male pattern hair growth in women - is effective in treating hidradenitis suppurativa in females and which dose of the drug works the best. Participation in this study will take about 4 clinic visits over approximately 7 months with the option to continue for longer if desired.

Timeline

Start
2020-09-21
Primary completion
2021-06-21
Completion
2021-06-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Spironolactone Small molecule 50 mg Oral
Comparator Spironolactone Small molecule 100 mg Oral
Comparator Spironolactone Small molecule 200 mg Oral